Dose ranging study of the effect of paroxetine on COAT-platelet [collagen and thrombin stimulated platelet] production in normal volunteers and patients with cardiovascular disease
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2008
At a glance
- Drugs Paroxetine (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 21 Sep 2008 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 11 Dec 2005 New trial record.